Kamada Ltd (KMDA) stock, explained like you're 5

Is Kamada Ltd a small, medium or large cap company?

No. Kamada Ltd is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 466 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Kamada Ltd makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves KMDA stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• (KMDA) Volatility Zones as Tactical Triggers (Stock Traders Daily)
• KMDA or PRTA: Which Is the Better Value Stock Right Now? (Yahoo Finance)
• Two drug launches in Israel expand Kamada (KMDA)'s portfolio as it projects sales through 2030. (Stock Titan)
• Should Value Investors Buy Kamada (KMDA) Stock? (Yahoo Finance)
• No pre approval inventory costs were booked as assets in 2024 25, Kamada (KMDA) says. (Stock Titan)

Key terms to know before you follow KMDA

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility